OTC · ECIA
Healthcare · Medical - Instruments & Supplies
$0.04
Up+$0.00 (+0.00%)
Updated Aug 16, 2026, 12:31 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 6 trading sessions · Daily adjusted prices
ECIA closed at $0.04 after 6 trading sessions, down 43.07% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 11, 2026 | $0.0427 | $0.0427 | $0.0427 | $0.0427 | 375 |
| Aug 10, 2026 | $0.035 | $0.035 | $0.035 | $0.035 | 5K |
| Aug 5, 2026 | $0.0503 | $0.0503 | $0.0503 | $0.0503 | 200 |
| Jul 31, 2026 | $0.12 | $0.12 | $0.12 | $0.12 | 7K |
| Jul 29, 2026 | $0.0975 | $0.15 | $0.0975 | $0.15 | 1.83K |
| Jul 28, 2026 | $0.075 | $0.075 | $0.075 | $0.075 | 157 |
The latest Smart Investors Daily articles mentioning ECIA.
ECIA research
Company profile and research snapshot.
ENCISION INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Finnhub · May 4, 2026
BOULDER, CO / ACCESS Newswire / May 4, 2026 / Encision Inc. , a medical device company that owns patented Active Electrode Monitoring technology designed to prevent dangerous stray energy burns in...
Finnhub · Apr 13, 2026
BOULDER, CO / ACCESS Newswire / April 13, 2026 / Encision Inc. , a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in...
accessnewswire.com · Nov 14, 2025
BOULDER, CO / ACCESS Newswire / November 14, 2025 / Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2026 second quarter that ended September 30, 2025. The Company posted quarterly product net revenue of $1.48 million and service net revenue of $46 thousand, or total net revenue of $1.52 million, resulting in a quarterly net loss of $268 thousand, or $(0.02) per diluted share.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ECIA.
No results
No recent SID articles mention ECIA.
